Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management

Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management

Background: Atrial fibrillation (AF) is a risk factor for cerebrovascular diseases and vascular dementia (VAD). The aim of this study was to evaluate the effect of the adherence to anticoagulant therapy guidelines in patients with dementia and AF on the risk of stroke/TIA or major bleeding (MB). Met...

Full description

Bibliographic Details
Main Authors:	Giovanna Viticchi, Lorenzo Falsetti, Marco Burattini, Vincenzo Zaccone, Laura Buratti, Marco Bartolini, Gianluca Moroncini, Mauro Silvestrini
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	Brain Sciences
Subjects:	vascular dementia atrial fibrillation anticoagulants CHA<sub>2</sub>DS<sub>2</sub>-VAS score HAS-BLED score
Online Access:	https://www.mdpi.com/2076-3425/10/7/420

Similar Items

Mortality Prediction of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation
by: Doralisa Morrone, et al.
Published: (2020-12-01)

Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice
by: K. G. Pereverzeva, et al.
Published: (2019-01-01)

The CHA<sub>2</sub>DS<sub>2</sub>-VAS<sub>C</sub> Score Predicts Mortality in Patients Undergoing Coronary Angiography
by: Nicholay Teodorovich, et al.
Published: (2023-10-01)

Antitrombotik berdasarkan skor CHA2DS2-VASc dan skor HAS BLED terhadap pola pengobatan pada pasien stroke iskemik dengan fibrilasi atrium
by: Rizaldy Taslim Pinzon, et al.
Published: (2017-06-01)

Evolution of CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Predicting Risk of Stroke Development in Patients with Atrial Fibrillation
by: A. O. Rubanenko
Published: (2023-05-01)

Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation
by: Anat Bel-Ange, et al.
Published: (2021-05-01)

Cardiovascular Events and Mortality in Patients on Hemodialysis: The Prognostic Value of the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score
by: Theodoros Tourountzis, et al.
Published: (2024-01-01)

Problem of prescribing anticoagulant therapy in patients with atrial fibrillation on the regional level
by: M. G. Nazarkina, et al.
Published: (2020-08-01)

Assessment and comparison of CHADS2, CHA2DS2-VASc, and HAS-BLED scores in patients with atrial fibrillation in Saudi Arabia
by: Abdulrahman M Al-Turaiki, et al.
Published: (2016-01-01)

Lack of Sex Disparity in Oral Anticoagulation in Atrial Fibrillation Patients Presenting with Ischemic Stroke in a Rural Population
by: Eric Koza, et al.
Published: (2021-10-01)

Empiric Anticoagulation Therapy in Hospitalized COVID-19 Patients: An Evaluation of Bleeding Risk Scores Performances in Predicting Bleeding Events
by: Mona A. Abdelrahman, et al.
Published: (2022-08-01)

Mitral Annular Calcification and Thromboembolic Risk
by: Paula Cristina Morariu, et al.
Published: (2023-07-01)

The CHA<sub>2</sub>DS<sub>2</sub>-VASc Score Predicts New-Onset Atrial Fibrillation and Hemodynamic Complications in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
by: Dan Alexandru Cozac, et al.
Published: (2022-10-01)

Pulmonary Vein Isolation Outcome Degree Is a New Score for Efficacy of Atrial Fibrillation Catheter Ablation
by: Ruzica Jurcevic, et al.
Published: (2021-12-01)

Therapeutic duplication of anticoagulants: a retrospective study of frequency and consequences in a tertiary referral hospital
by: Ramin Rahmanzade, et al.
Published: (2020-08-01)

Quality Improvement in the Preoperative Evaluation: Accuracy of an Automated Clinical Decision Support System to Calculate CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores
by: Chantal van Giersbergen, et al.
Published: (2022-09-01)

Predictive Value of HAS-BLED Score Regarding Bleeding Events and Graft Survival following Renal Transplantation
by: Hans Michael Hau, et al.
Published: (2022-07-01)

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
by: Joshua D. Brown, et al.
Published: (2018-03-01)

Performance of the ABC-bleeding risk score for assessing major bleeding risk in Chinese patients with atrial fibrillation on oral anticoagulation therapy: A real-world study
by: Yu-Feng Wang, et al.
Published: (2022-11-01)

A Retinal Oct-Angiography and Cardiovascular STAtus (RASTA) Dataset of Swept-Source Microvascular Imaging for Cardiovascular Risk Assessment
by: Clément Germanèse, et al.
Published: (2023-09-01)

Atrial fibrillation and CHA2DS2VASc score of 1 - is there a problem in clinical practice?
by: E. I. Baranova, et al.
Published: (2020-04-01)

Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study
by: Cecilia Politi, et al.
Published: (2016-02-01)

RETRACTED: Validation of the CHA2DS2-VA Score (Excluding Female Sex) in Nonvalvular Atrial Fibrillation Patients: A Nationwide Population-Based Study
by: Sun Young Choi, et al.
Published: (2022-03-01)

Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR
by: Sadik Volkan Emren, et al.
Published: (2020-01-01)

Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Akshyaya Pradhan, et al.
Published: (2020-10-01)

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study
by: Xiang W, et al.
Published: (2015-03-01)

Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database Representing the Japanese Population
by: Kubota K, et al.
Published: (2022-04-01)

Complex chronic patients as an emergent group with high risk of intracerebral haemorrhage: an observational cohort study
by: Blanca Lorman-Carbó, et al.
Published: (2021-02-01)

CHADS2 score has a better predictive value than CHA2DS2-VASc score in elderly patients with atrial fibrillation
by: Xing YL, et al.
Published: (2016-07-01)

Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study
by: Ting Liu, et al.
Published: (2020-01-01)

Prognostic value of interleukin-34 and interleukin-38 in patients with newly diagnosed atrial fibrillation
by: Jiaxue Ma, et al.
Published: (2023-01-01)

Can men with atrial fibrillation really rest easy with a CHA2DS2-VASc score of 0?
by: Chen-Di Cheng, et al.
Published: (2019-07-01)

Corrigendum: Differential Risk of Dementia Between Patients With Atrial Flutter and Atrial Fibrillation: A National Cohort Study
by: Hui-Ting Wang, et al.
Published: (2021-12-01)

Revised HAS‐BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants
by: Komsing Methavigul
Published: (2022-06-01)

Stroke risk stratification in atrial fibrillation: a review of common risk factors
by: Oreoluwa Oladiran, et al.
Published: (2019-03-01)

Mitral Regurgitation and Body Mass Index Increase the Predictability of Perioperative Bleeding in Anticoagulated Patients With Nonvalvular Atrial Fibrillation
by: Hao Huang, et al.
Published: (2022-03-01)

CURRENT POSSIBILITIES OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov, et al.
Published: (2015-10-01)

Use of simplified HAS‐BLED score in patients with atrial fibrillation receiving warfarin
by: Komsing Methavigul, et al.
Published: (2019-10-01)

Atrial Fibrillation in Adult Congenital Heart Increase Ischemic Stroke Risk Even at Low CHA2DS2-VASc Score
by: Yu-Sheng Lin, et al.
Published: (2023-08-01)

Incremental Value of the CRUSADE, ACUITY, and HAS‐BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy
by: Francesco Costa, et al.
Published: (2015-12-01)